Key result
Second-line gemcitabine resulted in long-term disease stabilization in a patient with refractory metastatic haemangioendothelioma.
Second-line gemcitabine may provide long-term disease stabilization in refractory metastatic haemangioendothelioma.
Pintoffl, Jan; Meisinger, Ines; Mayer, Frank; Horger, Marius; Weyhern, Claus von; Kanz, Lothar; Hartmann, Joerg Thomas Author Information
No takes yet. Share an insight, caveat, or question.
Pintoffl et al. (2008) studied this question. Second-line gemcitabine resulted in long-term disease stabilization in a patient with refractory metastatic haemangioendothelioma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: